Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Protein Controls Lymphoma Cell Metabolism, Promotes Cancer Growth
Disease Discoveries

Protein Controls Lymphoma Cell Metabolism, Promotes Cancer Growth

By Melissa RohmanSep 20, 2023
Share
Facebook Twitter Email
Jaehyuk Choi, MD, PhD, the Jack W. Graffin Professor and an associate professor of Dermatology and of Biochemistry and Molecular Genetics, was senior author of the study published in Nature Cancer.

Northwestern Medicine investigators have discovered how the protein PD-1 controls essential metabolic processes in tumor cells to promote cancer growth in T-cell non-Hodgkin lymphomas (T-NHLs), according to a study published in Nature Cancer.

“We found that PD-1 controls the metabolism of these T-cell lymphoma cells, and these metabolic changes completely reprogram the epigenetics and transcriptional signatures of the T-cell lymphomas themselves,” said Jaehyuk Choi, MD, PhD, the Jack W. Graffin Professor and associate professor of Dermatology and of Biochemistry and Molecular Genetics.

Jay Daniels, a student in the Driskill Graduate Program in Life Sciences (DGP), was co-lead author of the study.

The PD-1 protein, which is encoded by the PDCD1 gene, is known to act as a tumor suppressor in T-NHLs, which causes white blood cells called lymphocytes to grow abnormally and form tumors throughout the body.

The cancer is highly aggressive, and few treatment options are available due to a limited understanding of the mechanisms that drive PD-1 tumor suppression. However, a recent study from the Choi laboratory found that increased PD-1 mutations are actually associated with disease progression and poor prognosis.

To identify these mechanisms, Choi’s team performed RNA-sequencing and metabolic imaging to study tumor cells from mouse models of T-NHLs and samples of patient T-NHL tumors. Using these techniques, the investigators discovered that PD-1 restricts and regulates a number of essential metabolic processes within T-cell lymphoma cells, thereby increasing the aggressiveness of the cancer cells.

Jay Daniels, a student in the Driskill Graduate Program in Life Sciences (DGP), was co-lead author of the study.

“We had discovered previously there were 86 driver genes and we were surprised to find that this one mutation [in PD-1]seems to completely govern the lymphoma behavior,” Choi said.

The investigators also administered an enzyme inhibitor compound in the PD1-deficient mice, which prevented intracellular signaling in the T-NHL cells.

“Our data suggests that there could be a therapeutic opportunity to target specific pathways using FDA-approved drugs specifically only for the PD-1 mutant lymphomas,” Choi said.

In the future, these unique molecular features could be used as criteria for determining the severity and stage of T-NHLs and could improve treatment strategies for patients, according to Choi.

“We’re also really interested in trying to figure out whether this should be important criteria for determining how to use current therapies and also how to design clinical trials,” Choi added.

Joan Guitart, MD, chief of Dermatopathology in the Department of Dermatology, and Calvin Law, a DGP student, were co-authors of the study.

Choi and Guitart are members of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

This work was supported by supported by the National Institutes of Health (1DP2AI136599-01), the American Cancer Society Research Scholar Grant RSG-20-050-01, the Bakewell Foundation and the Leukemia Lymphoma Society Scholar Award (1377-21), and National Cancer Institute grants F30 CA265107 and T32 CA009560.

Biochemistry and Molecular Genetics Cancer Dermatology
Share. Facebook Twitter Email

Related Posts

AI May Spare Breast Cancer Patients Unnecessary Treatments

Dec 7, 2023

Drug Extends Survival in Prostate Cancer with Genetic Mutations  

Dec 6, 2023

Pioneering Biochemist Craig Crews Named Winner of 2024 Kimberly Prize

Dec 5, 2023

Comments are closed.

Latest News

Evolving Telehealth Research and its Place in Healthcare Delivery 

Dec 8, 2023

Global Health Day Highlights Pandemic, HIV Research

Dec 8, 2023

AI May Spare Breast Cancer Patients Unnecessary Treatments

Dec 7, 2023

Drug Extends Survival in Prostate Cancer with Genetic Mutations  

Dec 6, 2023

Pioneering Biochemist Craig Crews Named Winner of 2024 Kimberly Prize

Dec 5, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
2023-Sim-Open-House_161
2023-Sim-Open-House_127
2023-Sim-Open-House_108
2023-Sim-Open-House_106
2023-Sim-Open-House_118
2023-Sim-Open-House_068
2023-Sim-Open-House_069
2023-Sim-Open-House_027
2023-Sim-Open-House_155
2023-Sim-Open-House_161
2023-Sim-Open-House_127
2023-Sim-Open-House_108

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.